1008-8296
2006 Issue 4
yi yu zheng de gui fan yong yao
li guang zhi
li guang zhi
..............page:262-263
tang niao bing huan zhe ru he chi shui guo
sun xi hui
sun xi hui
..............page:261-261
..............page:259-260
..............page:256-258
..............page:255-256
Treatment of Parkinson disease: advances in neuroprotection
Yan Yunin;Wei Wenshi
Yan Yunin;Wei Wenshi
..............page:253-254
..............page:250-252
Ischemic brain impairment and apoptosis of nuron
Zhang Xinyong
Zhang Xinyong
..............page:248-250
Variation of immune system in the aged and elderly multiple organ failure
Zhu Qinglei;Wang shiwen
Zhu Qinglei;Wang shiwen
..............page:244-248
STUDY ON EXECUTIVE FUNCTION AND ENCEPHALOFLUCTUOGRAPH TECHNOLOGY IN EARLY PARKINSONIAN PATIENTS
Zhang Li;Wei Wenshi;Zhu Guoxing;Hong Zhen
Zhang Li;Wei Wenshi;Zhu Guoxing;Hong Zhen
..............page:225-228
NOS EXPRESSION AND NEURON APOPTOSIS IN RAT AFTER BRAIN ISCHEMIA-REPERFUSION AND THE PROTECTIVE EFFECT OF IMIPRAMINE
Zhang Xinyong;Wang Shiwei;Hou Yuntian;Gao Wei;Yi Yin;Zhu Qinglei
Zhang Xinyong;Wang Shiwei;Hou Yuntian;Gao Wei;Yi Yin;Zhu Qinglei
..............page:221-224
ANALYSIS OF THE RELATIVE FACTORS AND THE CLINICAL CHARACTERISTICS OF PARKINSON DISEASE
Ye Xiaolai;Zhang Jing;Wang Ying;Wu Yiwen;Chen Shengdi
Ye Xiaolai;Zhang Jing;Wang Ying;Wu Yiwen;Chen Shengdi
..............page:218-220,224
THE EFFICACY AND SAFETY OF SELEGILINE IN TREATMENT OF PARKINSON'S DISEASE: MULTI-CENTER, RANDOMIZED AND OPEN CLINICAL TRIAL
Zhang Jing;Ding Zhengtong;Huang Jianzheng;Ding Xinsheng;Guo Mingguang;Su Huilin;Wang Ying;Jiang Yuping;Mao Shanying;Dong Hairong;Wang Zhiying;Chen Shengdi
Zhang Jing;Ding Zhengtong;Huang Jianzheng;Ding Xinsheng;Guo Mingguang;Su Huilin;Wang Ying;Jiang Yuping;Mao Shanying;Dong Hairong;Wang Zhiying;Chen Shengdi
..............page:214-217
..............page:212-213,231
Surgical therapy on Parkinson disease
Sun Bomin
Sun Bomin
..............page:208-211,217
Sleep disorders on Parkinson disease
Zhao Zhongxin;Huang Liuqing
Zhao Zhongxin;Huang Liuqing
..............page:205-208
MONTHLY ATTACK RATE AND CLINICAL CHARACTERISTICS OF COMMUNITY ACQUIRED PNEUMONIA (CAP) AMONG OLD PEOPLE
Zhang Beiyan;Bai Qingrui;Yang Xi;Gao Xiaodong;Pu Chun;Xu Biao
Zhang Beiyan;Bai Qingrui;Yang Xi;Gao Xiaodong;Pu Chun;Xu Biao
..............page:241-243
STUDY OF PAINLESS COLONOSCOPY IN ELDERLY
Chen Peilian;Sun Shaoxiao;Huang Yiming;Zhen Meifeng;Xiang Ping;Gu Youming;Zhen Xiaoli
Chen Peilian;Sun Shaoxiao;Huang Yiming;Zhen Meifeng;Xiang Ping;Gu Youming;Zhen Xiaoli
..............page:238-240
EFFICACY AND SAFETY OF HAZZAR IN ELDERLY HYPERTENSION
Zhu Yi;Shi Kailei;Gong Ling;Qiu Chaohui;Zhu Yixi;Yu Liya
Zhu Yi;Shi Kailei;Gong Ling;Qiu Chaohui;Zhu Yixi;Yu Liya
..............page:235-237,243
SURVEY OF COGNITIVE FUNCTION STATE IN ROUTINE PHYSICAL EXAMINATION FOR RETIRED PEOPLE IN QINHUANGDAO HARBOUR
Wang Lingling;Zhu Xiaohong;Ju Xihuan;Wu Peng;Chen Ruidong;Fan Guoming;Li Yue;An Pingshun;Shao Yan;Ma Chunxin;Fang Da;Wu Kehua;Lu Fengyu
Wang Lingling;Zhu Xiaohong;Ju Xihuan;Wu Peng;Chen Ruidong;Fan Guoming;Li Yue;An Pingshun;Shao Yan;Ma Chunxin;Fang Da;Wu Kehua;Lu Fengyu
..............page:232-234
THE OBSERVATION OF COGNITIVE DEFICITS IN EARLY IDIOPATHIC PARKINSON'S DISEASE
Wei Wenshi;Zhang Xiaping;Ding Ping
Wei Wenshi;Zhang Xiaping;Ding Ping
..............page:229-231
Congnitive impairment on Parkinson disease should not be neglected
Chen Shengdi;Tan Yuyan
Chen Shengdi;Tan Yuyan
..............page:202-205
Progress in research on the pathogenesis of Parkinson disease
Wang Faxiang;Peng Guoguang
Wang Faxiang;Peng Guoguang
..............page:199-202
Progress of epidemiology on Parkinson disease
Cheng Qi;Yang Yan;Jiang Guoxin
Cheng Qi;Yang Yan;Jiang Guoxin
..............page:197-199
Pay attention to prevent and treat psychic symptoms on Parkinson disease
Chen Shengdi;Zhou Haiyan
Chen Shengdi;Zhou Haiyan
..............page:195-196
To prevent and treat congnitive impairment, the whole elderly should be cared
Yu Zhuowei;Ma Yongxing
Yu Zhuowei;Ma Yongxing
..............page:193-194